Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity. Blood Kohrt, H. E., Sagiv-Barfi, I., Rafiq, S., Herman, S. E., Butchar, J. P., Cheney, C., Zhang, X., Buggy, J. J., Muthusamy, N., Levy, R., Johnson, A. J., Byrd, J. C. 2014; 123 (12): 1957-1960
View details for DOI 10.1182/blood-2014-01-547869
View details for PubMedID 24652965